> [Original Message]
> From: CDER MEDWATCH LISTSERV <[EMAIL PROTECTED]>
> To: <[EMAIL PROTECTED]>
> Date: 2/7/2007 8:46:02 PM
> Subject: FDA MedWatch: Heparin Sodium Injection 10,000 units/mL and
HEP-LOCK U/P 10 units/mL associated with fatal medication errors
>
> MedWatch - The FDA Safety Information and Adverse Event Reporting Program
>
> Baxter and FDA notified healthcare professionals of the potential for
> life threatening medication errors involving two Heparin products,
> Heparin Sodium Injection 10,000 units/mL, and HEP-LOCK U/P 10 units/mL.
> Baxter is aware of fatal medication errors that have occurred when two
> Heparin products with shades of blue labeling were mistaken for each
> other. Three infant deaths resulted when the higher dosage Heparin
> Sodium Injection 10,000 units/mL was inadvertently administered instead
> of the lower dosage of HEP-LOCK U/P 10 units/mL. The currently marketed
> 1 mL vials of both Heparin products use blue as the prominent background
> color on their labels. 
>
> Read the complete MedWatch 2007 Safety summary, including a link to the
> Baxter Dear Healthcare Provider letter, at: 
>
> http://www.fda.gov/medwatch/safety/2007/safety07.htm#Heparin 
>
> _________________________________________________________________
>
> To ensure delivery of these timely alerts to your in-box and prevent
rejection of the notice by a spam filter, please add our MedWatch address,
[EMAIL PROTECTED], to your address book.
>
> Thank you for using FDA MedWatch as a trusted source for timely safety
information on drugs, devices and diagnostics regulated by the U.S. Food
and Drug Administration. If you find this e-mail notification helpful,
please consider telling colleagues and friends about MedWatch and this
e-mail notification process.  They can learn more and subscribe to the
e-list at http://www.fda.gov/medwatch.
>
> To send a comment or question to the MedWatch program:
http://www.fda.gov/medwatch/feedback.htm
>
> To unsubscribe from this listserve:
> https://list.nih.gov/cgi-bin/wa?SUBED1=medwatch&A=1


Reply via email to